HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial.
about
Skin grafting and tissue replacement for treating foot ulcers in people with diabetesDressings and topical agents for arterial leg ulcersFuture Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A ReviewAdvances in Skin Regeneration Using Tissue EngineeringA review of tissue-engineered skin bioconstructs available for skin reconstruction.A two-component pre-seeded dermal-epidermal scaffold.Cutaneous tissue engineering and lower extremity wounds (part 2).Total contact cast wall load in patients with a plantar forefoot ulcer and diabetes.Emerging drugs for diabetic foot ulcers.Cost of managing chronic wounds in the U.K., with particular emphasis on maggot debridement therapy.A natural history and framework for managing diabetic foot ulcers.Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes.Dermal substitute-assisted healing: enhancing stem cell therapy with novel biomaterial design.Hyaluronic acid derivatives and their healing effect on burns, epithelial surgical wounds, and chronic wounds: a systematic review and meta-analysis of randomized controlled trials.The role of skin substitutes in the management of chronic cutaneous wounds.Diabetic foot wounds: the value of negative pressure wound therapy with instillation.Effectiveness of hyaluronic acid for treating diabetic foot: a systematic review and meta-analysis.Skin substitutes: an overview of the key players in wound management.Dermal matrices and bioengineered skin substitutes: a critical review of current options.Systematic review and meta-analysis of skin substitutes in the treatment of diabetic foot ulcers: Highlights of a Cochrane systematic review.Effectiveness of hyaluronic acid and its derivatives on chronic wounds: a systematic review.Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up.Tissue-engineered provisional matrix as a novel approach to enhance diabetic wound healing.Tissue engineered skin for diabetic foot ulcers: a meta-analysis.Poly(hydroxybutyrate-co-hydroxyvalerate) bilayer skin tissue engineering constructs with improved epidermal rearrangement.Autologous skin substitute for hard-to-heal ulcers: retrospective analysis on safety, applicability, and efficacy in an outpatient and hospitalized setting.Immunological challenges associated with artificial skin grafts: available solutions and stem cells in future design of synthetic skin.Hypoxia pretreatment of bone marrow-derived mesenchymal stem cells seeded in a collagen-chitosan sponge scaffold promotes skin wound healing in diabetic rats with hindlimb ischemia.Randomised controlled clinical trial for autologous fibroblast-hyaluronic acid complex in treating diabetic foot ulcers.Spray-assisted layer-by-layer assembly on hyaluronic acid scaffolds for skin tissue engineering.Hyaluronic acid dressing (Healoderm) in the treatment of diabetic foot ulcer: A prospective, randomized, placebo-controlled, single-center study.
P2860
Q24186150-D1FC683D-5E54-474E-8C76-DF4AA1067D21Q24243007-A842EFCC-747E-439E-89A0-35F60F39C0CFQ28077861-F719F085-7B20-48DC-90EB-65581A8B31FDQ33624600-6A1D6BFB-0646-40E6-B7EF-E2629EDE0F11Q33742864-48895503-81A8-417A-ABF3-F83CA225C617Q34622754-A8268EAF-74E2-4FF6-A7F0-25930997FED5Q36423558-DA6D6F83-341D-4195-823F-B35B9CD714E3Q36439738-1C66EF6E-D90B-4A39-9045-834E757B0098Q36634279-F8A5D0E1-FAE8-4EE8-9532-E7CCF58BDAE3Q36662644-1CBD2EF4-D04C-4AE8-A439-798E5B38D1A9Q37261534-2A838C4A-8801-4D09-B9FA-DC9C52CAE0E5Q37340287-066DE13D-A488-4CF9-ABE2-188812008865Q37848691-C0C08804-1CA6-440B-925C-3A5F5850FB82Q38008034-89F6A5E4-37DD-47B7-8AD6-A70CF6826120Q38084327-E7F9AADB-DCB5-4629-8FF6-E1DD4661D649Q38164105-73FF242D-021F-4209-8CA9-B73958AB6639Q38231346-4E3EC3DD-211A-4C3E-A5FC-FD517AD01772Q38265174-07B5CB77-8838-41E2-BF94-F524980942D0Q38352535-B6ADB9D5-710B-4AC2-9818-870E0828F2CAQ38803328-B928CCA8-616C-4155-B016-798B42941832Q38967030-AA72A8C1-15BF-4996-A151-E17B7CD31DCCQ39263891-DCA57EAF-A59C-48D4-A527-608880DC8C06Q39677727-ECEA5C06-73FE-48D2-9735-6C9A6D9C77B6Q41572785-0D541310-A833-453A-9A2E-7122B79356D2Q42455205-90DCBDD5-8EBD-40D9-9A29-8CDA2599386FQ43857270-E88C21DC-41D0-4441-B2AA-3CE558A38AADQ47122472-2E87BDF6-3FE7-42EC-9F53-E17E813E5279Q51687489-FFC0878F-E87A-400F-B252-BF6AEEDB6147Q53396712-10E366F7-CA48-4EAF-A4AB-CA0D0EE33E5BQ53591763-3331199E-A787-4108-A057-87D6E2B43033Q53626381-A8A4D85F-9E30-4DC4-9630-2FC0357C6805
P2860
HYAFF 11-based autologous dermal and epidermal grafts in the treatment of noninfected diabetic plantar and dorsal foot ulcers: a prospective, multicenter, controlled, randomized clinical trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
HYAFF 11-based autologous derm ...... ed, randomized clinical trial.
@en
HYAFF 11-based autologous derm ...... ed, randomized clinical trial.
@nl
type
label
HYAFF 11-based autologous derm ...... ed, randomized clinical trial.
@en
HYAFF 11-based autologous derm ...... ed, randomized clinical trial.
@nl
prefLabel
HYAFF 11-based autologous derm ...... ed, randomized clinical trial.
@en
HYAFF 11-based autologous derm ...... ed, randomized clinical trial.
@nl
P2093
P1433
P1476
HYAFF 11-based autologous derm ...... ed, randomized clinical trial.
@en
P2093
Alberto Morabito
Carlo Caravaggi
Chiara Pritelli
Ezio Faglia
Giacomo Clerici
Giulio Mariani
Luca Dalla Paola
Manuela Mantero
Manuela Sommaria
Pietro Fratino
P304
P356
10.2337/DIACARE.26.10.2853
P407
P577
2003-10-01T00:00:00Z